Elliptic Laboratories A (ELABS.OL) Stock Price

Elliptic Laboratories A Price

Oslo Børs·CLOSED
3.20
​
Market closed

Revenue has compounded at 29.4% per year over the past 8 years to 75.72 M NOK. Elliptic Laboratories A's net margin stands at -182.5%, down from -21.8% several years earlier.

Elliptic Laboratories A stock price

Access this data via the Eulerpool API

Elliptic Laboratories A business model & stock analysis

Elliptic Laboratories ASA engages in the development of applications from its patented AI platform, which combines ultrasound and sensor-fusion algorithms to deliver intuitive 3D gesture, proximity and presence sensing experiences. The company is headquartered in Oslo, Oslo and currently employs 64 full-time employees. The company went IPO on 2020-10-16. The enterprise targets the smartphone, laptop, IoT, and automotive markets. The Company’s Artificial Intelligence (AI) software combines ultrasound and sensor-fusion algorithms to deliver intuitive 3D gesture and presence sensing experiences. Elliptic Laboratories ASA has offices in San Francisco, Oslo and Shanghai.

Frequently asked questions about Elliptic Laboratories A

9 analysts currently rate the Elliptic Laboratories A stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Elliptic Laboratories A to generate revenue of 99.54 M NOK and earnings per share of -0.16 NOK.

Converted at the current exchange rate, the Elliptic Laboratories A share trades at 0.30 EUR (3.20 NOK).

The Elliptic Laboratories A share (ELABS.OL) is listed on 6 stock exchanges, including: Osaka (JPX) (ELABS.OL), Frankfurt (EIP.F), München (EIP.MU), Stockholm (ELABSO.ST).

The expected revenue of Elliptic Laboratories A is 99.54 M NOK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Elliptic Laboratories A is -20.80 M NOK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Elliptic Laboratories A is currently -19.85. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Elliptic Laboratories A stock.

The price-to-sales ratio (P/S) of Elliptic Laboratories A is currently 4.15. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Elliptic Laboratories A stock.

The Eulerpool Quality Score for Elliptic Laboratories A is 2/10.

The ISIN of Elliptic Laboratories A is NO0010722283. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Elliptic Laboratories A is A2QFQQ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Elliptic Laboratories A is ELABS.OL. The ticker symbol is used to trade Elliptic Laboratories A shares on the stock exchange.

Fair ValueTerminal
2.98 NOK
Over-/UndervaluationTerminal
Fairly valued
Industry
Software
Number of shares
Employees
Revenue per Employee
1.18 M NOK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Norway
Currency
NOK
Initial public offering
Oct 16, 2020
ISIN
NO0010722283
Cusip
R21796108
Market capitalization
337.45 M NOKSmall Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee 2026
-19.85
P/Ee 2027
-177.31
P/Ee 2028
42.99
P/S
P/Se
4.15
EV/EBIT
—
P/B Ratio
1.78
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-69.75 %
Gross Margin
16.73 %
EBIT Margin
-60.01 %
Net Margin
-182.46 %
EPS (Earnings Per Share)
-1.07 NOK
Net Debt / EBIT
0.65
Debt/Equity
0.04
Last updated Oct 5, 2026, 6:17 PM

Elliptic Laboratories A Peer Group

Elliptic Laboratories A Ticker

EURONEXT · ELABS.OLFRANKFURT · EIP.FMUNICH · EIP.MUOSE · ELABS.OLOSLO · ELABS.OLSTOCKHOLM · ELABSO.ST

Elliptic Laboratories A FIGI

ELABS:NO · BBG00XSL39K5ELABSNOK:EP · BBG00XWZ5VS0ELABSNOK:EZ · BBG00XWZ5VV6ELABSNOK:XS · BBG00XWZ5VW5ELABSNOK:X2 · BBG00XWZ5VX4ELABSNOK:XH · BBG00XWZ5VZ2ELABSNOK:XF · BBG00XWZ5W17ELABSNOK:XE · BBG00XWZ5W35ELABSNOK:XJ · BBG00XWZ5W44ELABSNOK:XL · BBG00XWZ5W53ELABSNOK:XG · BBG00XWZ5W62ELABSNOK:XO · BBG00XWZ5W71

All fundamentals and in-depth analysis of Elliptic Laboratories A

Our stock analysis for Elliptic Laboratories A stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Elliptic Laboratories A. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.